Review

Remdesivir: Review of Pharmacology, Pre-clinical Data, and Emerging Clinical Experience for COVID-19.

Pharmacotherapy. 2020 Jul 1; 40 (7): 659-671.
Review

Remdesivir (GS-5734) in COVID-19 Therapy: The Fourth Chance.

Curr Drug Targets. 2021 Jan 1; 22 (12): 1346-1356.
Review

Insight into 2019 novel coronavirus - an updated intrim review and lessons from SARS-CoV and MERS-CoV.

Int. J. Infect. Dis. 2020 May 1; 94: 119-124.